Activated protein C resistance and lupus anticoagulant in pregnancy.
Thrombophilias, both inherited and acquired, have been reported to be associated with thromboembolic events and severe obstetric complications. This case report examines the case of a patient with two thrombophilias, activated protein C resistance secondary to Factor V Leiden mutation and lupus anticoagulant.
Busowski
J D
JD
Department of Obstetrics and Gynecology, University of South Carolina School of Medicine, Columbia 29203, USA.
Jenkins
A D
AD
Hale
E U
EU
Busowski
M
M
Dacus
J V
JV
D020016:Activated Protein C Resistance / Q000175:diagnosis* / Q000628:therapy; D000293:Adolescent; D001034:Apgar Score; D001241:Aspirin / Q000627:therapeutic use; D005165:Factor V / Q000032:analysis* / Q000235:genetics; D005260:Female; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007231:Infant, Newborn; D016682:Lupus Coagulation Inhibitor / Q000097:blood*; D010314:Partial Thromboplastin Time; D011247:Pregnancy; D011248:Pregnancy Complications / Q000097:blood / Q000175:diagnosis* / Q000276:immunology / Q000628:therapy; D011250:Pregnancy Complications, Hematologic / Q000097:blood / Q000175:diagnosis / Q000628:therapy
D016682:Lupus Coagulation Inhibitor; C095381:factor V Leiden; D005165:Factor V; D006493:Heparin; D001241:Aspirin